摘要
DNA甲基化异常是人类肿瘤中常见的表观遗传变化之一,伴随着肿瘤的发生和发展,且该异常现象在肿瘤患者的外周循环血清、血浆和尿液等体液中都可检测到。因此,利用DNA甲基化分析技术检测体液中特定分子DNA甲基化水平是肿瘤早期诊断、病程监控和疗效评估的潜在手段,对临床肿瘤的诊治意义重大。
Abnormal methylation of DNA in certain genomic regions is a frequent epigenetic alteration that is involved in Human tumorigenesis and development. Various studies have shown that this aberrant DNA modification can be detected in body fluids of tumor patients, e. g. circulating blood, sputum, urine. So the evaluation of DNA methylation in these body fluids by methylaion detection methods can be utilized as a potential biomarker for early cancer detection and accurately clinical assess. This plays a significant role in cancer diagnosis and treatment.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2006年第2期131-135,共5页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
上海市科委重大科技攻关项目资助课题(№04DZ19211)